You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 1.1% | 1.1% |
| Div Cover | 8.6 | 7.7 |
| Op Mrgn | 8.3% | 20.0% |
| ROCE | 29.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | 10.8 | 11.4 |
| PEG | 0.5 | -2.5 |
| Price / Revenue | 1.9 | 1.8 |
| Price / Book value | 2.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 10.4% | -3.8% |
| PBT | 83.7% | n/a |
| EPS | 20.6% | -20.0% |
| DPS | 13.6% | -13.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | 339.90 | 15.90 | 33.40p | 18.1 | 0.9 | 19% | 4.00p | 0.7% |
| 2017-06-30 | 302.30 | 14.10 | 41.30p | 20.8 | 0.9 | 24% | 5.00p | 0.6% |
| 2018-06-30 | 381.20 | 35.90 | 45.40p | 20.2 | 2.0 | 10% | 5.60p | 0.6% |
| 2019-06-30 | 456.90 | 12.30 | 54.40p | 18.5 | 0.9 | 20% | 6.70p | 0.7% |
| 2020-06-30 | 504.30 | 22.60 | 65.60p | 12.4 | 0.6 | 21% | 7.61p | 0.9% |
| Clinigen performs well despite Covid-19 impact on H1 Sharecast News | 14 Jan |
|---|---|
| Clinigen taps Sam Herbert for chief operating officer Sharecast News | 04 Jan |
| Clinigen trades in line despite ongoing Covid-19 impact Sharecast News | 26 Nov |
| Half Year trading update | 14-Jan-21 07:04 |
|---|---|
| Holding(s) in Company | 22-Dec-20 15:21 |
| Appointment of Nominated Adviser and Joint Broker | 18-Dec-20 07:08 |
| Holding(s) in Company | 15-Dec-20 07:07 |
| Holding(s) in Company | 11-Dec-20 15:40 |